FGFR2の変異および耐性変異に対して活性を示す、初の高選択的FGFR2阻害剤RLY-4008の補足付録S1

Subbiahら（Mon,）はこの問題を研究した。

www.synapsesocial.com/papers/68e586b5b6db643587522e97 — DOI: https://doi.org/10.1158/2159-8290.27025775.v1

Also consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. Supplementary Figure S1 from RLY-4008, the first highly selective FGFR2 inhibitor with activity across FGFR2 alterations and resistance mutations· 2024
2. Supplementary Figure S1 from RLY-4008, the first highly selective FGFR2 inhibitor with activity across FGFR2 alterations and resistance mutations· 2024
3. Supplementary References from RLY-4008, the first highly selective FGFR2 inhibitor with activity across FGFR2 alterations and resistance mutations· 2024
4. Supplementary References from RLY-4008, the first highly selective FGFR2 inhibitor with activity across FGFR2 alterations and resistance mutations· 2024
5. Supplementary Figure S2 from RLY-4008, the first highly selective FGFR2 inhibitor with activity across FGFR2 alterations and resistance mutations· 2024